Loading publications…
The last 5 uploaded publications
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma, Evelyn Regar, Nieves Gonzalo, Héctor M. García‐García, Koen Nieman, Nico Bruining, Cécile Dorange, Karine Miquel‐Hébert, Susan Veldhof, Mark Webster, Leif Thuesen, Dariusz Dudek (2009). A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. The Lancet, 373(9667), pp. 897-910, DOI: 10.1016/s0140-6736(09)60325-1.
Article147 days agoA bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A. Ormiston, Patrick W. Serruys, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Mark Webster, Yoshinobu Onuma, Héctor M. García‐García, Robert McGreevy, Susan Veldhof (2008). A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. The Lancet, 371(9616), pp. 899-907, DOI: 10.1016/s0140-6736(08)60415-8.
Article147 days agoEvaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis
Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Pieter C. Smits, Jacques Koolen, Bernard Chevalier, Bernard De Bruyne, Leif Thuesen, Dougal McClean, Robert‐Jan van Geuns, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Krishnankutty Sudhir, Héctor M. García‐García, John A. Ormiston (2011). Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis. Journal of the American College of Cardiology, 58(15), pp. 1578-1588, DOI: 10.1016/j.jacc.2011.05.050.
Article147 days agoA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.
Patrick W. Serruys, P. Ruygrok, Jörg Neuzner, Jan J. Piek, Ashok Seth, Joachim Schofer, Gert Richardt, Marcus Wiemer, Didier Carrié, Leif Thuesen, Els Boone, Karine Miquel-Herbert, Joost Daemen (2006). A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.. PubMed, 2(3), pp. 286-94
Article147 days agoEvaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis
Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston, Bernard De Bruyne, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel‐Hébert, Richard Rapoza, Héctor M. García‐García (2010). Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis. Circulation, 122(22), pp. 2301-2312, DOI: 10.1161/circulationaha.110.970772.
Article147 days ago